A RESEARCH STUDY TO ASCERTAIN THE RESTLESSNESS FACTOR AMONG THE PATIENTS OF HEPATITIS C INFECTION by Dr Saleha Javed, Dr Yasir Ashfaq, Dr Zainab Bibi
IAJPS 2019, 06 (03), 6069-6073                    Saleha Javed et al                         ISSN 2349-7750 
 
 
 
w w w . i a j p s . c o m  
 
Page 6069 
 
        CODEN [USA]: IAJPBB                        ISSN: 2349-7750 
 
  INDO AMERICAN JOURNAL OF 
 PHARMACEUTICAL SCIENCES 
                              
Available online at: http://www.iajps.com                                  Research Article 
A RESEARCH STUDY TO ASCERTAIN THE RESTLESSNESS 
FACTOR AMONG THE PATIENTS OF HEPATITIS C 
INFECTION 
Dr Saleha Javed, Dr Yasir Ashfaq, Dr Zainab Bibi 
Sheikh Zayed Hospital Rahim Yar Khan 
Article Received: January 2019        Accepted: February 2019           Published: March 2019 
Abstract: 
Background: All around the globe, the health of people has suffered due to infection of hepatitis C. Experts are of the 
view that interferon therapy is not established, depression can be the outcome of Hepatitis C Infection. 
Objective: The objective of the research was to determine the restlessness in patients of Hepatitis C. 
Patients and Methods: The time duration of this research span from January 2017 to May 2017. The research was 
organized at Mayo Hospital, Lahore on a total of 100 patients including 42 male and 58 female patients. These patients 
were presented in the outdoor patients’ department. These patients were positive for HCV and were not treated for 
the management of the disease. The interview was taken from these patients. Results were entered in a Performa and 
Hamilton Rating Scale for depression. SPSS was used for data assessment. 
Results: 37.82 years was the mean age of all the participants. The number of patients found with depression, mild 
depression, moderate depression, severe depression and very severe depression was respectively 38%, 12%, 20%, 4% 
and 2%. 
Conclusion: It is concluded by the results that non treated patients of hepatitis C were depressed. It also indicated 
that Hepatitis C may also cause depression among patients. 
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INTRODUCTION: 
The discovery of Hepatitis C is the most frequent 
blood-borne infection caused by a virus. All around 
the world, 180 million people are suffered from 
Hepatitis C. It is also the main reason for chronic liver 
disorder [1]. In some parts of Pakistan, the incidence 
of hepatitis C has been observed as 35% [2, 3]. 
According to experts’ point of view, HCV infection 
and clinical restlessness are directly linked [1]. 
Interferon therapy is not available. Due to this, the 
occurrence of fatigue, co-morbid depression and 
cognitive decline is common [4]. As compared to the 
common pollution, the incidence of depression in the 
patients of HCV is high, according to DSM-IV 
criteria. In the common population, 6 – 10 percent 
people are found with depression. Whereas, the 
incidence of depression in patients of HCV is found in 
24 to 70 percent of people [4]. 
 
Management of depressed HCV infected patients 
become easy and disability is reduced if depression is 
treated [5]. Otherwise, depression can result in fatigue 
and increased somatic complaints. Keeping in view 
the occurrence of depression among people, it should 
be taken seriously by patients and physicians. The 
objective of this research was to determine restlessness 
in patients of hepatitis C. 
 
PATIENTS AND METHODS: 
The time duration of this research span from January 
2017 to May 2017. The research was organized at 
Mayo Hospital, Lahore on a total of 100 patients 
including 42 male and 58 female patients. These 
patients were presented in the outdoor patients’ 
department. These patients were selected from both 
the genders. The age limit of the participants was 
above thirteen years. An agreement was signed by all 
the patients. On the basis of DSM-IV standard, 
depressive symptomatology and the comprehensive 
record were from all the pre-diagnosed HCV positive 
patients visiting the outdoor patient department and 
not receiving any treatment for Hepatitis C [6]. All the 
patients were interviewed and all the data was 
assembled on the Performa. Those were excluded 
from research who were with complex diabetes, heart 
failure, cirrhotic liver disorder, hepatic failure, 
hypothyroidism and renal failure. Patients indicated 
prior with HCV were selected for this research. They 
were not receiving any treatment. We determined the 
rate of depression in these patients. It is indicated by 
some researchers that depression results from some 
pathology of the virus itself. These patients were 
positive for HCV and were not treated for the 
management of the disease. The interview was taken 
from these patients. Results were entered in a 
Performa and Hamilton Rating Scale for depression 
[7]. SPSS was used for data assessment. 
 
RESULTS: 
37.82 years was the mean age of all the participants. 
The number of patients found with depression, mild 
depression, moderate depression, severe depression 
and very severe depression was respectively 38%, 
12%, 20%, 4% and 2%. The number of males was 42 
and the female was 58. Of these, 26 (44.82%) and 12 
(28.5%) females and males were depressed 
respectively as far as sex differences are concerned in 
the prevalence of depression. Two patients (2%) 
thought of suicidal attempt. None of the patients was 
found with medication and mental healthcare 
provision for the management of depression. In the age 
group of 21 – 50 years, the incidence of depression 
was high. It is followed by 41 – 50 years (28%) and 21 
– 40 years (22%). 
 
Table – I: Gender Distribution 
 
Gender (Percentage) Normal Depressed 
Male 72 28 
Female 56 44 
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Table – II: Level of Depression 
 
Level of Depression Frequency 
Mild 12 
Moderate 20 
Normal 62 
Severe 4 
Very Severe 2 
Total 100 
 
 
 
 
Table – III: Distribution of Age Group 
 
Age Group Frequency 
13 - 20 Years 4 
21 - 30 Years 30 
31 - 40 Years 22 
41 - 50 Years 28 
51 - 60 Years 14 
61 - 65 Years 2 
Total 100 
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DISCUSSION: 
All around the globe including Pakistan, the health of 
people is affected by hepatitis C. It is also expected in 
the coming years. As compared to the common 
community, quality of life is affected and 
psychological indications are high commonly in 
patients with hepatitis C and other medical disorders 
[3]. Depression is also observed in these patients [8 – 
10]. It was indicated in the study conducted by 
Elshahwi et al. that the percentage of patients 
untreated with IFN is 30% [9]. 28% and 35% was the 
limit of patients found with depression in previous 
research studies [11 – 13]. The occurrence of 
depression in our research was noticed in 38% of 
cases, which is comparable with other studies. 
Regardless of the presence of substance abuse or 
alcohol and IFN-alpha treatment, depression is a result 
of chronic hepatitis C [14]. Complications, doubts, 
incapability and changeable course of the disease as 
enteropathogenic factors found in this group [15]. In 
these patients, depression is mainly caused by the 
perception of stigma, changes in brain metabolites as 
evident by magnetic resonance imaging spectroscopy 
and emotional volatility [16]. 
 
CONCLUSION: 
Based on the outcomes, it is concluded that depression 
is present in untreated patients of hepatitis C. It 
indicates virus itself cause of depression by disease 
pathology. In order to assess the relationship between 
depression and HCV, there is a need for a well-
organized research study. To estimate the depression 
in time, psychiatric assessment is required at the start 
of therapy. 
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